Rodabe N Amaria
Overview
Explore the profile of Rodabe N Amaria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
5214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salem A, Chen M, Williams M, Swanson D, McQuade J, Amaria R, et al.
Head Neck
. 2025 Feb;
PMID: 39906003
Objective: We aim to evaluate outcomes for patients with resectable SNMM treated in the immunotherapy era. Methods: Thirty-seven patients with resectable SNM were identified using our institutional database between 2016...
2.
Keatts S, Salem A, Swanson D, Farooqi A, Bishop A, Amaria R, et al.
Clin Transl Radiat Oncol
. 2024 Sep;
49:100856.
PMID: 39308633
Background And Purpose: As patients with advanced melanoma live longer in the context of systemic therapy advancements, better strategies for durable control of bulky tumors are needed. In this study,...
3.
Saberian C, Milton D, Simon J, Amaria R, Diab A, McQuade J, et al.
Neurooncol Pract
. 2024 Jul;
11(4):452-463.
PMID: 39006528
Background: Melanoma leptomeningeal disease (LMD) has a poor prognosis. However, the management of patients with advanced melanoma has evolved with time, including those with LMD. We reviewed a large cohort...
4.
Gopalakrishnan M, Amaria R
Clin Cancer Res
. 2024 May;
30(14):2862-2864.
PMID: 38743418
Leveraging a heterogeneous dataset, a recent article demonstrated the application of pharmacometric modeling to inform the dosing of nivolumab-relatlimab fixed-dose combination in special populations, including adolescents lacking clinical data. The...
5.
Glitza Oliva I, Ferguson S, Bassett Jr R, Foster A, John I, Hennegan T, et al.
Nat Med
. 2024 Apr;
30(6):1787.
PMID: 38649781
No abstract available.
6.
Garbe C, Dummer R, Amaral T, Amaria R, Ascierto P, Burton E, et al.
Nat Med
. 2023 May;
29(6):1310-1312.
PMID: 37193799
No abstract available.
7.
Marques-Piubelli M, Seervai R, Mudaliar K, Ma W, Milton D, Wang J, et al.
J Cutan Pathol
. 2023 May;
50(7):661-673.
PMID: 37150813
Background: Immune checkpoint inhibitor (ICI)-based cancer therapies cause a variety of cutaneous immune-related adverse events (irAEs) including immunobullous skin eruptions like bullous pemphigoid (BP). However, little is known about the...
8.
Hieken T, Kreidieh F, Aedo-Lopez V, Block M, McArthur G, Amaria R
Am Soc Clin Oncol Educ Book
. 2023 Apr;
43:e390614.
PMID: 37116111
Clinical stage III melanoma, defined as resectable RECIST measurable nodal disease with or without in-transit metastases, represents approximately 15% of new melanoma diagnoses every year with additional cases presenting as...
9.
Glitza Oliva I, Ferguson S, Bassett Jr R, Foster A, John I, Hennegan T, et al.
Nat Med
. 2023 Mar;
29(4):898-905.
PMID: 36997799
There is a critical need for effective treatments for leptomeningeal disease (LMD). Here, we report the interim analysis results of an ongoing single-arm, first-in-human phase 1/1b study of concurrent intrathecal...
10.
Amaria R, Postow M, Burton E, Tetzlaff M, Ross M, Torres-Cabala C, et al.
Nature
. 2023 Mar;
615(7953):E23.
PMID: 36894629
No abstract available.